Open seminar on antimicrobial resistance: Science, Policy and Global Action
Department of Chemistry, Department of Biomedicine, Department of Clinical Science and Department of Government are hosting an open seminar for all interested in the topic of antimicrobial resistance (AMR).
Antimicrobial resistance (AMR) is reducing the effectiveness of life-saving treatments, posing a serious and growing threat to global health and undermining the foundations of modern medicine. The latest WHO report shows that resistance to essential antibiotics, particularly among Gram-negative bacteria, is widespread, increasing and unevenly distributed. As a result first-choice treatments for common infections of the bloodstream, urinary tract and gastrointestinal tract are becoming increasingly ineffective.
The burden is greatest in low- and middle-income countries (LMICs) where AMR surveillance coverage, microbiological diagnostic capacity and access to effective alternative treatments may be limited. The combination of high resistance levels and weaker health systems disproportionately affects the most vulnerable populations.
If you would like to learn more, join us for the free Open seminar on AMR on Wednesday, 14 October, at Nygårdsgaten 5, UiB.
Registration for the seminar: “Antibiotic Resistance: Science, Policy and Global Action”, (deadline 11th October, 2026)
Program:
09:30 – 10:00 Registration and mingling
10:00 – 10:05 Opening
10:05 – 10:50 Antibiotic resistance in a global perspective – How dangerous is it and what can be done to reduce the threat? – Professor Bjørn Blomberg, Faculty of Medicine, University of Bergen
10:50 – 11:35 Legal and policy implications of antibiotic discovery and development – Assoc. Prof. Helen Yu, Swansea University, Wales, UK
11:35 – 12:30 Lunch
12:30 – 13:15 What’s the problem? Governance capacity and governance legitimacy in crises – Professor Lise Hellenbø Rykkja, Faculty of Social Sciences, University of Bergen
13:15-14:00 Strategic importance of resistance surveillance in the fight against AMR – Dr. Stephen Hawser, InternaAonal Health Management Associates
14:00-14:30 Coffee break
14:30 – 15:15 Developing next-generation antibiotics: Challenges and opportunities – Professor Anders Karlén, Coordinator ENABLE-2, Uppsala University, Sweden
15:15 Closing remarks